Hurler Syndrome Treatment Market - Industry Trendst
Hurler
Syndrome Treatment Market - Industry Trends and Forecast to 2027 with key
players like Takeda Pharmaceutical Company Limited, Sanofi, F. Hoffmann-La
Roche Ltd, Bayer AG, Pfizer Inc, Cipla Inc, DAIICHI SANKYO COMPANY LIMITED
Hurler
Syndrome Treatment Market By Drugs (Elosulfase Alfa, Laronidase and
Others), Treatment (Medication, Enzyme Replacement Therapy, Hematopoietic Stem
Cell Transplant (HSCT) and Surgery), Route of Administration (Oral and
Parenteral), Distribution Channel (Direct, Online Pharmacy, Retailers and
Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa) -
Industry Trends and Forecast to 2027
Market Analysis: Global
Hurler Syndrome Treatment Market
Hurler syndrome
treatment market is growing at a steady CAGR in the forecast period of 2021-2026.
The report contains data of the base year 2018 and historic year 2017. This
rise in market value can be attributed to the increase in awareness among the
population about the syndrome and its treatment.
Download full sample report of Hurler
syndrome treatment market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hurler-syndrome-treatment-market
Market Outlook: Global
Hurler Syndrome Treatment Market
Hurler syndrome is
formally known as mucopolysaccharidosis type 1, a distinct form of lysosomal
storage disease. It is caused by either mutation or malfunctioning of enzyme
called alpha-L-iduronidase which helps in breaking down of sugar molecules
called glycosaminoglycans and results in accumulation of
glycosaminoglycans which increases the size of the lysosomes and
eventually leads to enlargement of tissues and organ.
MPS I or Hurler syndrome
occurs in about 1 in every 100,000 births worldwide and it is divided into
three categories according to the type, severity and the progression symptoms.
Attenuated MPS I occurs in less than 1 in 500,000 births and least common
amongst all.
Market Drivers
Increasing prevalence of Hurler syndrome across the world may
drive the market for Hurler syndrome
Rise in investment from government, public & private
organizations for the development of novel drugs to treat genetic disorders is
boosting the market growth in the forecast period
Innovations and developments in treatment is accelerating the
market growth
Market Restraints
High possibilities of substance abuse and addiction involved in
the treatment of Hurler syndrome is expected to restrain the market growth
Complications and severity involved in treatment is hampering
the market
High cost of available treatment and lack of awareness among the
rural population in developing and under develop countries is hindering the
market in the forecast period
Global Hurler Syndrome
Treatment Market Scope and Market Size:
Global
Hurler syndrome treatment market is segmented of the basis of treatment,
drugs, route of administration, distribution channel and end-users. The growth
among these specific segments will help users analyze niche pockets of growth
and strategies to approach the market and determine your core application areas
and difference in your target markets.
Based on treatment, the
hurler syndrome treatment market is segmented into medication, enzyme
replacement therapy, Hematopoietic Stem Cell Transplant (HSCT) and surgery
Based on drug, the
hurler syndrome treatment market is segmented as elosulfase alfa, laronidase
and others
Based on the route of
administration, the hurler syndrome treatment market is segmented into oral and
parenteral
Based on the
distribution channel, the hurler syndrome treatment market is segmented as
direct, online pharmacy, retailers and others
Based on end-users, the
hurler syndrome treatment market is segmented into hospitals, homecare,
specialty clinics and others
Global Hurler Syndrome
Treatment Market Country Level Analysis
The countries covered in
the market report are U.S., Canada and Mexico in North America, Germany,
France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey,
Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe,
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand,
Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi
Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and
Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of
South America as part of South America.
Key Developments in the Market
In November 2017, ArmaGen received the Fast Track designation
from the U.S FDA for AGT-181, a novel drug to treat patients with Hurler
syndrome (also known as mucopolysaccharidosis type I or MPS I). This
designation provides incentives to assist and encourage the development of
drugs for rare diseases.
In February 2016, Sangamo Therapeutics received the U.S FDA
clearance of Investigational New Drug Application for SB-318, a single
treatment strategy intended to provide a life-long therapy for
Mucopolysaccharidosis Type I (MPS I). If trial gets successful it will greatly
enhance the company’s portfolio of orphan diseases and increasing quality life
for patients and their families.
Competitive Analysis:
Hurler syndrome
treatment market is highly fragmented and the major players have used various
strategies such as new product launches, expansions, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market. The report includes market shares of Hurler syndrome treatment
drug market for Global, Europe, North America, Asia-Pacific, South America and
Middle East & Africa.
Key Market Players:
The key market players
in the Hurler syndrome treatment market are Novartis AG, Takeda Pharmaceutical
Company Limited, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Pfizer Inc, Cipla
Inc, DAIICHI SANKYO COMPANY, LIMITED, LUPIN, CENTOGENE AG, BioMarin, Magenta
Therapeutics, ArmaGen, Bellicum Pharmaceuticals, Inc, Nuo Therapeutics, Inc,
Sangamo Therapeutics among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-hurler-syndrome-treatment-market
Reasons
for Buying this Report
This report provides pin-point analysis for changing
competitive dynamics
It provides a forward looking perspective on different
factors driving or restraining market growth
It provides a six-year forecast assessed on the basis
of how the market is predicted to grow
It helps in understanding the key product segments and
their future
It provides pin point analysis of changing competition
dynamics and keeps you ahead of competitors
It helps in making informed business decisions by
having complete insights of market and by making in-depth analysis of market
segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-hurler-syndrome-treatment-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @
PDLC (Polymer Dispersed Liquid Crystal) for
Smart Window Market
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
